
CareTrust REIT (CTRE) Stock Forecast & Price Target
CareTrust REIT (CTRE) Analyst Ratings
Bulls say
CareTrust REIT is viewed positively because it is aggressively deploying capital into healthcare real estate at accretive returns, including the $764 million acquisition on October 1 and another $669 million expected throughout 2027 in the LNT transaction. The staggered UK care home portfolio offers a low-5.0% cash yield during lease-up, rising to a mid-/high-6.0% yield in year 1 of operations, while management’s broader activity includes $1.4 billion of deals YTD and a $540 million pipeline. With tenant credit concerns stabilizing, stronger SNF fundamentals, and estimated core earnings growth of 17.7% in 2026, 9.8% in 2027, and 6.4% in 2028, the stock appears positioned for continued NAV and AFFO expansion.
Bears say
CareTrust REIT is viewed negatively because its earnings trajectory depends heavily on a fragile skilled nursing reimbursement environment, where Medicaid cuts could tighten operator economics and stall growth at its 2026 run-rate. The outlook is further clouded by unpredictable SNF regulation, potential headline risk tied to PACS and the still-unresolved DOJ investigation, and the possibility that intensified competition will make future acquisitions harder and more costly. With valuation vulnerable to a pullback toward the 7-year historical average multiple of about 14.0x, the stock faces downside if cost of capital rises or operator labor pressures weaken tenant stability.
This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.
CareTrust REIT (CTRE) Analyst Forecast & Price Prediction
Start investing in CareTrust REIT (CTRE)
Order type
Buy in
Order amount
Est. shares
0 shares